AR063788A1 - Derivados de 5-hidroximetil-oxazolidin -2-ona - Google Patents

Derivados de 5-hidroximetil-oxazolidin -2-ona

Info

Publication number
AR063788A1
AR063788A1 ARP070105031A ARP070105031A AR063788A1 AR 063788 A1 AR063788 A1 AR 063788A1 AR P070105031 A ARP070105031 A AR P070105031A AR P070105031 A ARP070105031 A AR P070105031A AR 063788 A1 AR063788 A1 AR 063788A1
Authority
AR
Argentina
Prior art keywords
hydroximethyl
oxazolidin
ona
derivatives
opo3h2
Prior art date
Application number
ARP070105031A
Other languages
English (en)
Spanish (es)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39170372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR063788(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of AR063788A1 publication Critical patent/AR063788A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
ARP070105031A 2006-11-10 2007-11-12 Derivados de 5-hidroximetil-oxazolidin -2-ona AR063788A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2006054189 2006-11-10

Publications (1)

Publication Number Publication Date
AR063788A1 true AR063788A1 (es) 2009-02-18

Family

ID=39170372

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105031A AR063788A1 (es) 2006-11-10 2007-11-12 Derivados de 5-hidroximetil-oxazolidin -2-ona

Country Status (27)

Country Link
EP (1) EP2086968B1 (enExample)
JP (2) JP4484965B2 (enExample)
KR (1) KR101118402B1 (enExample)
CN (1) CN101535305B (enExample)
AR (1) AR063788A1 (enExample)
AT (1) ATE544764T1 (enExample)
AU (1) AU2007318901B2 (enExample)
BR (1) BRPI0718862B8 (enExample)
CA (1) CA2668280C (enExample)
CL (1) CL2007003232A1 (enExample)
CY (1) CY1112696T1 (enExample)
DK (1) DK2086968T3 (enExample)
ES (1) ES2380388T3 (enExample)
HR (1) HRP20120385T1 (enExample)
IL (1) IL198645A (enExample)
MA (1) MA30960B1 (enExample)
MX (1) MX2009004764A (enExample)
MY (1) MY148847A (enExample)
NO (1) NO344727B1 (enExample)
NZ (1) NZ577538A (enExample)
PL (1) PL2086968T3 (enExample)
PT (1) PT2086968E (enExample)
RU (1) RU2453546C2 (enExample)
SI (1) SI2086968T1 (enExample)
TW (1) TWI374138B (enExample)
WO (1) WO2008056335A1 (enExample)
ZA (1) ZA200904028B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
BRPI0409955A (pt) 2003-04-30 2006-04-25 Morphochem Ag Komb Chemie uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
MXPA06006769A (es) 2003-12-18 2006-12-19 Morphochem Ag Komb Chemie Antibioticos hibridos de oxazolidinona-quinolona.
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US8124623B2 (en) 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
BRPI0911991B8 (pt) * 2008-05-09 2021-05-25 Actelion Pharmaceuticals Ltd derivados de 5-hidroximetil-oxazolidin-2-ona para o tratamento de doenças intestinais bacterianas
PL2776431T3 (pl) * 2011-11-08 2016-11-30 Stanowiące antybiotyki pochodne 2-okso-oksazolidyno-3,5-diylu
LT3003289T (lt) 2013-05-28 2019-06-25 Morphochem Gmbh Oksazolidinono-chinolono hibrido kaip antibakterinio preparato įvedimas
CN105246476B (zh) 2013-05-28 2019-11-15 莫弗凯姆联合化学股份公司 含噁唑烷酮-喹诺酮的联合疗法在治疗细菌感染中的应用
WO2016079757A2 (en) * 2014-11-19 2016-05-26 Symed Labs Limited Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives
EP3421454B9 (en) * 2016-02-26 2023-08-09 Otsuka Pharmaceutical Co., Ltd. Piperidine derivative
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1156597A3 (ru) * 1982-04-28 1985-05-15 Е.И.Дюпон Де Немур Энд Компани (Фирма) Способ получени производных 3-( @ -алкилсульфонилфенил)оксазолидинона или их фармацевтически приемлемых кислотно-аддитивных солей
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
US6413981B1 (en) * 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6689769B2 (en) * 2000-12-21 2004-02-10 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
AU2002256995A1 (en) * 2001-02-07 2002-08-28 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
CN100544719C (zh) * 2003-04-30 2009-09-30 莫弗凯姆联合化学股份公司 噁唑烷酮-喹啉杂化物抗生素用于制备治疗炭疽和其它感染的药物中的用途
BRPI0409955A (pt) * 2003-04-30 2006-04-25 Morphochem Ag Komb Chemie uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções
MXPA06006769A (es) * 2003-12-18 2006-12-19 Morphochem Ag Komb Chemie Antibioticos hibridos de oxazolidinona-quinolona.
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물

Also Published As

Publication number Publication date
AU2007318901A1 (en) 2008-05-15
PL2086968T3 (pl) 2012-07-31
JP4484965B2 (ja) 2010-06-16
ATE544764T1 (de) 2012-02-15
PT2086968E (pt) 2012-04-13
JP2010509314A (ja) 2010-03-25
JP5490553B2 (ja) 2014-05-14
MA30960B1 (fr) 2009-12-01
EP2086968A1 (en) 2009-08-12
KR101118402B1 (ko) 2012-03-07
HRP20120385T1 (hr) 2012-06-30
BRPI0718862B8 (pt) 2021-05-25
ZA200904028B (en) 2010-08-25
KR20090075875A (ko) 2009-07-09
CA2668280A1 (en) 2008-05-15
MY148847A (en) 2013-06-14
MX2009004764A (es) 2009-05-21
SI2086968T1 (sl) 2012-06-29
RU2453546C2 (ru) 2012-06-20
TWI374138B (en) 2012-10-11
AU2007318901B2 (en) 2013-03-14
NO344727B1 (no) 2020-03-23
HK1136276A1 (en) 2010-06-25
NO20092209L (no) 2009-06-09
NZ577538A (en) 2011-11-25
CY1112696T1 (el) 2016-02-10
CN101535305B (zh) 2013-09-18
CL2007003232A1 (es) 2008-06-27
CA2668280C (en) 2015-02-10
IL198645A0 (en) 2010-02-17
ES2380388T3 (es) 2012-05-11
IL198645A (en) 2014-05-28
BRPI0718862A2 (pt) 2013-12-17
RU2009121812A (ru) 2010-12-20
EP2086968B1 (en) 2012-02-08
TW200829580A (en) 2008-07-16
WO2008056335A1 (en) 2008-05-15
DK2086968T3 (da) 2012-03-19
BRPI0718862B1 (pt) 2020-10-13
CN101535305A (zh) 2009-09-16
JP2010132677A (ja) 2010-06-17

Similar Documents

Publication Publication Date Title
AR063788A1 (es) Derivados de 5-hidroximetil-oxazolidin -2-ona
AR063925A1 (es) Antibacteriales 5-hidroximetil -oxazolidin-2-ona composicion farmaceutica que los comprende y su uso para tratar o prevenir infecciones bacterianas
PE20110150A1 (es) Amidofenoxiindazoles como inhibidores de c-met
CY1108230T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
TN2009000199A1 (en) Heteromonocyclic compound and use thereof
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
MX2010002820A (es) Analogos de tiazolidindiona para tratamiento de hipertension.
MX2010008460A (es) Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
SE0301232D0 (sv) Novel use
MA32956B1 (fr) Derives de 5-amino-2-(1-hydroxyethyl)-tetrahydropyrane
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
TW200700069A (en) Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
AR054608A1 (es) Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
UY30788A1 (es) Compuestos quimicos
NO20051011L (no) Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister
BR112012014091A2 (pt) inibidores de cisteína protease.
ECSP045396A (es) Proceso para preparar derivados de 6-alquiliden penem
PE20090445A1 (es) Inhibidores de produccion de beta amiloide
TW200728291A (en) Amide derivatives

Legal Events

Date Code Title Description
FG Grant, registration